Surgeon, Istituto Nazionale dei Tumori Milano
The Peritoneal Surface Malignancies (PSM) Program at the Fondazione IRCCS “Istituto Nazionale dei Tumori" of Milan (INT) has completed 20 years of experience. Main objective of the program was to promote clinical and scientific research to optimize the therapeutic strategies for patients with PSM. Core of the Program has been the integration of Cytoreductive Surgery (CRS) with Hyperthermic Intra-Peritoneal Chemotherapy (HIPEC) in the clinical practice, and more than 800 procedures have been performed thus far. The INT is a international oncological referral center that is in a privileged position to conduct translational research. In accordance with this mission, our activity has evolved in a multidisciplinary environment, with the participation of clinicians, biologists, pathologists, and pharmacologists. Therefore all studies have had a biological and pharmacological features. Several clinical trials have enabled to standardize the treatment of different PSM and define the treatment guidelines for many of them. Special attention was dedicated to rare PSM as Pseudomyxoma Peritonei, Serous Papillary Peritoneal Carcinoma, and Peritoneal Mesothelioma. Regarding the latter, in particular, we have recently structured and coordinated the Peritoneal Surface Oncology Group International (PSOGI) registry, gathering data on more than 1,000 patients. The output of our clinical and research activity has contributed to the evolution of the PSM field in the last two decades by means of several initiatives such as the Milan Consensus Conference in 2006. Moreover, we have also dedicated efforts to spread knowledge by means of PSM Theoretical Courses and coordination of European School of Peritoneal Surface Oncology (ESPSO) that is the last significant ESSO-PSOGI initiative.
Dr. Marcello Deraco is currently Responsible for Peritoneal Surface Malignancies at the Fondazione IRCCS Istituto Nazionale dei Tumori Milano-Italy.
Graduated in Medecine on July 1987; Post Graduated in General Surgery on October 1992 and in Oncology on 1993.
Marcello Deraco dedicated many clinical and scientific efforts during 25 years in the field of Peritoneal Surface Malignancies (PSM); as Principal Investigator he carried out several clinical-biological studies publishing more than 170 papers or book chapters. With over one thousand procedures performed, Dr. Deraco is an experienced surgeon performing Cytoreductive Surgery and Hyperthermic Intra Peritoneal Chemotherapy (HIPEC) to treat patients with PSM.
As Director of the 2006 Peritoneal Surface Oncology Group International (PSOGI) Milan Consensus Conference on Peritoneal Surface Malignancies he actively contributed to optimize recommendations and guide lines in this area.
Marcello Deraco is President of the SITILO. (Italian Society for Locoregional Treatment), Executive Board Member of PSOGI, Secretary GIMe (Italian Mesothelioma Group) and Co-Director of the European School for Peritoneal Surface Oncology (ESPSO) a ESSO-PSOGI initiative. Finally he is Member of several scientific societies as SSO (Society of Surgical Oncology), ESSO (European Society of Surgical Oncology) and SICO (Italian Society of Surgical Oncology).
Istituto Nazionale dei Tumori, Via Giacomo Venezian, Milaan, Italië